COL1A1 and myocardial infarction: Immunostaining of myofibroblast activation marker proteins α-SMA and COL1A1 further confirmed reduced cardiac fibrosis at the protein level, as both proteins were drastically reduced by 66% and 39% upon CPX treatment following MI, respectively (Figure 2F).